PRGO

#2158
PERRIGO COMPANY PLC
11.7400 USD
+2.80%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
11.7400
11.8000
Faixa anual
9.2250
22.0100
Mudança diária
+2.80%
Mudança mensal
+16.01%
Mudança em 6 meses
-45.45%
Mudança anual
-45.45%
Fechamento anterior
11.4200
Abrir
11.7950
Bid
Ask
Mínimo
11.7400
High
11.8000
Volume
109
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 1.616 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Fabricantes de medicamentos - especializados e genéricos
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.35
Índice preço/fluxo de caixa
0.45
Dividendos por ação
1.16
Rendimento de dividendos, %
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

Notícias